HLA-DM
HLA-DM is a protein complex involved in the immune system of humans. It plays a crucial role in the antigen presentation process, which is essential for the activation of T cells and the subsequent immune response. HLA-DM is part of the major histocompatibility complex (MHC) class II molecules and is encoded by the HLA-DM gene.
Structure[edit | edit source]
HLA-DM is a heterodimer composed of two subunits: the alpha (α) chain and the beta (β) chain. These subunits are encoded by the HLA-DMA and HLA-DMB genes, respectively. The protein complex is located within the endosomal and lysosomal compartments of antigen-presenting cells (APCs) such as dendritic cells, macrophages, and B cells.
Function[edit | edit source]
The primary function of HLA-DM is to facilitate the loading of antigenic peptides onto MHC class II molecules. This process occurs within the acidic environment of the endosomal/lysosomal compartments. HLA-DM interacts with the MHC class II molecules, stabilizing them and promoting the release of the invariant chain-derived peptide, known as CLIP (Class II-associated invariant chain peptide). This allows for the binding of high-affinity antigenic peptides to the MHC class II molecules, which are then transported to the cell surface for recognition by CD4+ T cells.
Mechanism[edit | edit source]
HLA-DM functions by catalyzing the exchange of CLIP for antigenic peptides. It acts as a molecular chaperone, ensuring that only peptides with high affinity for the MHC class II binding groove are presented on the cell surface. This selective process is critical for the accurate presentation of antigens and the activation of the adaptive immune response.
Clinical Significance[edit | edit source]
Mutations or deficiencies in HLA-DM can lead to impaired antigen presentation and are associated with various autoimmune diseases and immunodeficiency disorders. Understanding the role of HLA-DM in these conditions can provide insights into potential therapeutic targets for modulating immune responses.
Research[edit | edit source]
Ongoing research is focused on elucidating the detailed mechanisms of HLA-DM function and its interactions with other components of the antigen presentation pathway. Studies are also exploring the potential of targeting HLA-DM in vaccine development and immunotherapy.
See also[edit | edit source]
- Major histocompatibility complex
- Antigen presentation
- T cell
- B cell
- Dendritic cell
- Macrophage
- Autoimmune disease
- Immunodeficiency
References[edit | edit source]
External links[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD